Biphenyl

Biphenyl

SCHEMBL28338714

c1ccc(-c2ccccc2)cc1.c1ccc(-c2cccnc2)cc1

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 7/20 0.83
ALDH1A1 P00352 2/20 0.83
CYP3A4 P08684 2/20 0.83
CYP1A2 P05177 1/20 0.83
CYP19A1 P11511 2/20 0.65
MKNK1 Q9BUB5 4/20 0.63
MKNK2 Q9HBH9 4/20 0.63
KDM4E B2RXH2 1/20 0.61
LMNA P02545 1/20 0.61
TP53 P04637 1/20 0.61
MAPT P10636 1/20 0.61
HPGD P15428 1/20 0.61
ALOX15 P16050 1/20 0.61
HTT P42858 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
HSD17B10 Q99714 1/20 0.61
CYP11B2 P19099 2/20 0.59
KIF11 P52732 1/20 0.59
CYP17A1 P05093 1/20 0.59
CYP11B1 P15538 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16405704 1.00 CYP2A6 (0.83) CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1
SCHEMBL29500136 1.00 CYP2A6 (0.83) CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1
SCHEMBL141605 1.00 CYP2A6 (0.83) CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1
SCHEMBL3400752 0.97 CYP2A6 (0.79) CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1
SCHEMBL29234687 0.97 CYP2A6 (0.79) CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1
SCHEMBL29468039 0.97 CYP2A6 (0.79) CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1
SCHEMBL32679826 0.97 CYP2A6 (0.79) CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1
SCHEMBL31124557 0.97 CYP2A6 (0.79) CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1
SCHEMBL31588397 0.97 CYP2A6 (0.79) CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1
SCHEMBL30963953 0.97 CYP2A6 (0.79) CYP2A6ALDH1A1CYP3A4CYP1A2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112996486-A Local delivery of therapeutic agents comprising cell penetrating peptides for the treatment of age-related macular degeneration and other eye diseases K·罗伊兹曼 2021-06-18 CN disclosed
CN-110545836-A Treatment of age-related macular degeneration and other ocular diseases with apolipoprotein mimics MACREGEN INC 2019-12-06 CN disclosed